$0.5949
-0.32-35.08%
Last update: Nov 6, 7:58 PM
60 Degrees Pharmaceuticals Inc
SXTPNASDAQ
60 Degrees (SXTP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.86 | $-0.94 | $-2.11 | $-3.04 |
| Actual | $-0.90 | $-1.28 | $-1.47 | $-2.64 |
| Surprise | -4.65% | -36.2% | +30.3% | +13.2% |
| Revenue | ||||
| Estimate | $186000 | $436000 | $537000 | $242000 |
| Actual | $56798 | $76377 | $303385 | $437602 |
| Surprise | -69.5% | -82.5% | -43.5% | +80.8% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.83 | $-0.87 | $-0.90 | $-0.88 |
| Revenue | ||||
| Consensus | $276000 | $308000 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.90 | $-0.86 | -4.65 % |
| Q1 | May 15, 2026 | $-1.28 | $-0.94 | -36.2 % |
| Q4 | Mar 31, 2026 | $-1.47 | $-2.11 | 30.3 % |
| Q3 | Nov 13, 2025 | $-2.64 | $-3.04 | 13.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $56.80K | $186.00K | -69.5 % |
| Q1 | May 15, 2026 | $76.38K | $436.00K | -82.5 % |
| Q4 | Mar 31, 2026 | $303.39K | $537.00K | -43.5 % |
| Q3 | Nov 13, 2025 | $437.60K | $242.00K | 80.8 % |
